• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

壳聚糖纳米颗粒作为一种潜在的眼表药物递送系统:毒性、摄取机制及体内耐受性

Chitosan nanoparticles as a potential drug delivery system for the ocular surface: toxicity, uptake mechanism and in vivo tolerance.

作者信息

Enríquez de Salamanca Amalia, Diebold Yolanda, Calonge Margarita, García-Vazquez Carmen, Callejo Sagrario, Vila Ana, Alonso Maria José

机构信息

Instituto de Oftalmobiologia Aplicada (IOBA), University of Valladolid, Spain.

出版信息

Invest Ophthalmol Vis Sci. 2006 Apr;47(4):1416-25. doi: 10.1167/iovs.05-0495.

DOI:10.1167/iovs.05-0495
PMID:16565375
Abstract

PURPOSE

To study the in vitro and in vivo interaction of chitosan nanoparticles (CSNPs), a new particulate drug carrier, with epithelial cells on the ocular surface.

METHODS

CSNPs labeled with fluorescein isothiocyanate-bovine serum albumin were produced by ionotropic gelation. Human conjunctival epithelial cells (IOBA-NHC) were exposed for 15, 30, 60, and 120 minutes to three different CSNP concentrations. Immediately after treatment and after a 24-hour recovery period in culture medium, cell survival, and viability were measured. The association of CSNPs with IOBA-NHC cells was investigated by confocal microscopy. The influence of temperature and the effect of metabolic inhibition were studied by fluorometry. The in vivo uptake and acute tolerance of the ocular surface to CSNPs were evaluated in rabbits.

RESULTS

Cell survival and viability of CSNP-exposed cells were equivalent to that of the control. Uptake of CSNPs was continuous for the 2-hour duration of these experiments and was temperature dependent. Metabolic inhibition by sodium azide had no effect on CSNP uptake. The rabbit ocular surface showed no signs of inflammation or alteration after CSNP exposure compared with the control. Fluorescence microscopy of rabbit eyeball and lid sections confirmed in vivo uptake by conjunctival and corneal epithelia.

CONCLUSIONS

CSNPs were internalized by IOBA-NHC cells by an active transport mechanism that did not compromise cell viability. Moreover, these nanoparticles were well tolerated by the ocular surface tissues. These facts add further support for the potential use of these colloidal systems to delivery drugs to the ocular surface.

摘要

目的

研究新型颗粒药物载体壳聚糖纳米粒(CSNPs)与眼表上皮细胞的体外和体内相互作用。

方法

通过离子凝胶法制备异硫氰酸荧光素-牛血清白蛋白标记的CSNPs。将人结膜上皮细胞(IOBA-NHC)暴露于三种不同浓度的CSNPs中15、30、60和120分钟。处理后立即及在培养基中恢复24小时后,测量细胞存活率和活力。通过共聚焦显微镜研究CSNPs与IOBA-NHC细胞的结合情况。通过荧光测定法研究温度的影响和代谢抑制的作用。在兔体内评估眼表对CSNPs的摄取和急性耐受性。

结果

暴露于CSNPs的细胞的存活率和活力与对照组相当。在这些实验的2小时期间,CSNPs的摄取是持续的,并且依赖于温度。叠氮化钠的代谢抑制对CSNP摄取没有影响。与对照组相比,兔眼表在暴露于CSNPs后没有炎症或改变的迹象。兔眼球和眼睑切片的荧光显微镜检查证实结膜和角膜上皮在体内摄取了CSNPs。

结论

CSNPs通过一种不损害细胞活力的主动转运机制被IOBA-NHC细胞内化。此外,这些纳米粒在眼表组织中耐受性良好。这些事实进一步支持了这些胶体系统在向眼表递送药物方面的潜在用途。

相似文献

1
Chitosan nanoparticles as a potential drug delivery system for the ocular surface: toxicity, uptake mechanism and in vivo tolerance.壳聚糖纳米颗粒作为一种潜在的眼表药物递送系统:毒性、摄取机制及体内耐受性
Invest Ophthalmol Vis Sci. 2006 Apr;47(4):1416-25. doi: 10.1167/iovs.05-0495.
2
Ocular drug delivery by liposome-chitosan nanoparticle complexes (LCS-NP).脂质体-壳聚糖纳米颗粒复合物(LCS-NP)介导的眼部药物递送
Biomaterials. 2007 Mar;28(8):1553-64. doi: 10.1016/j.biomaterials.2006.11.028. Epub 2006 Dec 13.
3
Ocular tolerance to a topical formulation of hyaluronic acid and chitosan-based nanoparticles.眼部对透明质酸和壳聚糖基纳米粒子的局部制剂的耐受性。
Cornea. 2010 May;29(5):550-8. doi: 10.1097/ICO.0b013e3181bd9eee.
4
Novel hyaluronic acid-chitosan nanoparticles for ocular gene therapy.用于眼部基因治疗的新型透明质酸-壳聚糖纳米颗粒
Invest Ophthalmol Vis Sci. 2008 May;49(5):2016-24. doi: 10.1167/iovs.07-1077.
5
Bioadhesive hyaluronan-chitosan nanoparticles can transport genes across the ocular mucosa and transfect ocular tissue.生物黏附性透明质酸-壳聚糖纳米颗粒可携带基因穿过眼黏膜并转染眼组织。
Gene Ther. 2008 May;15(9):668-76. doi: 10.1038/gt.2008.16. Epub 2008 Feb 28.
6
The effects of 5-fluorouracil on ocular tissues in vitro and in vivo after controlled release from a multifunctional implant.多功能植入物控释后5-氟尿嘧啶对眼组织的体内外作用
Invest Ophthalmol Vis Sci. 2009 May;50(5):2216-23. doi: 10.1167/iovs.08-3016. Epub 2009 Jan 10.
7
Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery.用于非侵入性疫苗递送的单-N-羧甲基壳聚糖(MCC)和N-三甲基壳聚糖(TMC)纳米颗粒。
Int J Pharm. 2008 Nov 3;363(1-2):139-48. doi: 10.1016/j.ijpharm.2008.06.029. Epub 2008 Jul 9.
8
Chitosan nanoparticles are compatible with respiratory epithelial cells in vitro.壳聚糖纳米颗粒在体外与呼吸道上皮细胞具有相容性。
Eur J Pharm Sci. 2007 Jun;31(2):73-84. doi: 10.1016/j.ejps.2007.02.008. Epub 2007 Feb 25.
9
Studies on the transport pathway of PBCA nanoparticles in ocular tissues.聚氰基丙烯酸正丁酯纳米粒在眼组织中的转运途径研究。
J Microencapsul. 1991 Oct-Dec;8(4):497-504. doi: 10.3109/02652049109021873.
10
Protective effect of Coenzyme Q(10) against oxidative damage in human lens epithelial cells by novel ocular drug carriers.新型眼部药物载体对人晶状体上皮细胞氧化损伤的辅酶 Q(10)保护作用。
Int J Pharm. 2011 Jan 17;403(1-2):219-29. doi: 10.1016/j.ijpharm.2010.10.020. Epub 2010 Oct 29.

引用本文的文献

1
Roles of biomaterials in modulating the innate immune response in ocular therapy.生物材料在眼部治疗中调节先天性免疫反应的作用。
Front Drug Deliv. 2023 Feb 15;3:1077253. doi: 10.3389/fddev.2023.1077253. eCollection 2023.
2
Nanomedicine-Based Ophthalmic Drug Delivery Systems for the Treatment of Ocular Diseases.用于治疗眼部疾病的基于纳米医学的眼科药物递送系统
Int J Nanomedicine. 2025 Jul 21;20:9221-9249. doi: 10.2147/IJN.S532074. eCollection 2025.
3
Bovine ocular microbiome: the next frontier in managing Pinkeye in cattle.牛眼微生物群:牛红眼病防治的新前沿。
Anim Microbiome. 2025 Jun 4;7(1):58. doi: 10.1186/s42523-025-00425-9.
4
Comparative evaluation of nano ocular delivery systems loaded pH and thermosensitive in situ gels for Acanthamoeba keratitis treatment.负载pH和热敏原位凝胶的纳米眼部给药系统用于棘阿米巴角膜炎治疗的比较评价
Sci Rep. 2025 Jun 3;15(1):19430. doi: 10.1038/s41598-025-03418-5.
5
Nanochitin and Nanochitosan in Pharmaceutical Applications: Innovations, Applications, and Future Perspective.纳米几丁质与纳米壳聚糖在药物应用中的创新、应用及未来展望
Pharmaceutics. 2025 Apr 27;17(5):576. doi: 10.3390/pharmaceutics17050576.
6
Intraocular injectable hydrogels for the delivery of cells and nanoparticles.用于细胞和纳米颗粒递送的眼内注射水凝胶。
Mater Today Bio. 2025 Apr 12;32:101767. doi: 10.1016/j.mtbio.2025.101767. eCollection 2025 Jun.
7
Nanotherapy for Neural Retinal Regeneration.用于神经视网膜再生的纳米疗法。
Adv Sci (Weinh). 2025 Jun;12(24):e2409854. doi: 10.1002/advs.202409854. Epub 2025 Jan 14.
8
The postbiotic potential of - a narrative review.-的后生元潜力——一篇叙述性综述。 (你提供的原文中“-”处内容缺失,请补充完整以便能准确翻译。)
Front Microbiol. 2024 Oct 23;15:1452725. doi: 10.3389/fmicb.2024.1452725. eCollection 2024.
9
Chitosan as a promising materials for the construction of nanocarriers for diabetic retinopathy: an updated review.壳聚糖作为构建糖尿病视网膜病变纳米载体的一种有前景的材料:最新综述
J Biol Eng. 2024 Feb 22;18(1):18. doi: 10.1186/s13036-024-00414-7.
10
Formulation and In-Vitro/Ex-Vivo Characterization of Pregelled Hybrid Alginate-Chitosan Microparticles for Ocular Delivery of Ketorolac Tromethamine.用于酮咯酸氨丁三醇眼部给药的预胶凝海藻酸盐-壳聚糖杂化微粒的制剂及其体外/离体表征
Polymers (Basel). 2023 Jun 21;15(13):2773. doi: 10.3390/polym15132773.